Global Alternative Splicing Defects in Human Breast Cancer Cells

Area of Science:

• Molecular Biology
• Genomics
• Cancer Research

Background:

• Breast cancer is a leading cause of death in women globally.
• Alternative splicing (AS) generates protein diversity but aberrant AS contributes to cancer metastasis and treatment resistance.
• Identifying cancer-specific AS events is crucial for developing targeted therapies.

Purpose of the Study:

• To identify global breast cancer-specific alternative splicing defects.
• To validate the accuracy and clinical relevance of identified AS events.
• To explore the functional implications of these aberrant AS events in breast cancer.

Main Methods:

• RNA-mediated oligonucleotide annealing, selection, and ligation coupled with next-generation sequencing (RASL-seq) was employed.
• RT-PCR was used for validation of RASL-seq results.
• Analysis of AS events was performed using The Cancer Genome Atlas (TCGA) database and normal/cancerous breast tissue samples.

Main Results:

• RASL-seq successfully identified global breast cancer-specific AS defects with high accuracy, confirmed by RT-PCR.
• Analysis of TCGA data and patient samples validated these AS events.
• Aberrantly spliced cassette exons in breast cancer tissues encode intrinsically disordered protein regions, not known functional domains.

Conclusions:

• Novel alternative splicing errors in human breast cancer have been revealed.
• These AS defects may influence breast cancer progression and biological processes.
• The findings provide potential new targets for breast cancer therapeutic interventions.